Skip to main content
Top
Published in: Journal of General Internal Medicine 1/2022

01-01-2022 | Myalgie | Concise Research Report

Impact of Metformin on Statin Persistence: a Post Hoc Analysis of a Large Randomized Controlled Trial

Authors: Byron Cheon, MS, Ambuj Kumar, MD, MPH, Athanasios Tsalatsanis, PhD, Kevin Cowart, PharmD, MPH, Ronald R. Magness, PhD, Srinivas M. Tipparaju, PhD, Nicholas W. Carris, PharmD

Published in: Journal of General Internal Medicine | Issue 1/2022

Login to get access

Excerpt

Optimal cardiovascular disease (CVD) risk reduction is impaired by statin-associated muscle symptoms (SAMS).13 Severe muscle reactions are well accounted for, yet mild-to-moderate myalgia is common and difficult to track. No valid SAMS therapies exist, and management requires trial-and-error with different statins until one is tolerated.1
Literature
1.
go back to reference Grundy SM, Stone NJ, Bailey AL, et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019;139:e1046-e1081.PubMed Grundy SM, Stone NJ, Bailey AL, et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019;139:e1046-e1081.PubMed
2.
go back to reference Zhang H, Plutzky J, Skentzos S, et al. Discontinuation of statins in routine care settings: a cohort study. Ann Intern Med 2013;158(7):526-34.CrossRef Zhang H, Plutzky J, Skentzos S, et al. Discontinuation of statins in routine care settings: a cohort study. Ann Intern Med 2013;158(7):526-34.CrossRef
3.
go back to reference Carris NW, Tipparaju SM, Magness DJ, et al. Pleiotropic effects of metformin to rescue statin-induced muscle injury and insulin resistance: A proposed mechanism and potential clinical implications. Med Hypotheses 2017;107:39-44.CrossRef Carris NW, Tipparaju SM, Magness DJ, et al. Pleiotropic effects of metformin to rescue statin-induced muscle injury and insulin resistance: A proposed mechanism and potential clinical implications. Med Hypotheses 2017;107:39-44.CrossRef
4.
go back to reference Carris NW, Tsalatsanis A, Tipparaju SM, et al. Metformin's impact on statin-associated muscle symptoms: An analysis of ACCORD study data and research materials from the NHLBI Biologic Specimen and Data Repository Information Coordinating Center. Diabetes Obes Metab 2018;20:1994-9.CrossRef Carris NW, Tsalatsanis A, Tipparaju SM, et al. Metformin's impact on statin-associated muscle symptoms: An analysis of ACCORD study data and research materials from the NHLBI Biologic Specimen and Data Repository Information Coordinating Center. Diabetes Obes Metab 2018;20:1994-9.CrossRef
5.
go back to reference Ginsberg HN, Elam MB, Lovato LC, et al. Effects of combination lipid therapy in type 2 diabetes mellitus. N Engl J Med 2010;362:1563-74.CrossRef Ginsberg HN, Elam MB, Lovato LC, et al. Effects of combination lipid therapy in type 2 diabetes mellitus. N Engl J Med 2010;362:1563-74.CrossRef
6.
go back to reference Soric MM, Moorman JM, Boyle JA, Dengler-Crish CM. Prevalence and Predictors of Metformin Prescribing in Adults with Type 2 Diabetes Mellitus: A National Cross-Sectional Study. Pharmacotherapy. 2016;36:715-722.CrossRef Soric MM, Moorman JM, Boyle JA, Dengler-Crish CM. Prevalence and Predictors of Metformin Prescribing in Adults with Type 2 Diabetes Mellitus: A National Cross-Sectional Study. Pharmacotherapy. 2016;36:715-722.CrossRef
Metadata
Title
Impact of Metformin on Statin Persistence: a Post Hoc Analysis of a Large Randomized Controlled Trial
Authors
Byron Cheon, MS
Ambuj Kumar, MD, MPH
Athanasios Tsalatsanis, PhD
Kevin Cowart, PharmD, MPH
Ronald R. Magness, PhD
Srinivas M. Tipparaju, PhD
Nicholas W. Carris, PharmD
Publication date
01-01-2022
Publisher
Springer International Publishing
Published in
Journal of General Internal Medicine / Issue 1/2022
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-020-06344-6

Other articles of this Issue 1/2022

Journal of General Internal Medicine 1/2022 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.